Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Projections are in Place for the Hepatitis Therapeutics Market Between 2024-2033?
The market size for hepatitis treatments has seen consistent growth in the past few years. The market value, which was $18.35 billion in 2023, is projected to increase to $18.89 billion in 2024, at a compound annual growth rate (CAGR) of 3.0%. The growth during the historical period is credited to factors such as development of vaccines, antiviral drugs, public health drives, funding for research, and the advent of emerging therapies.
In the coming years, a consistent expansion is predicted for the hepatitis therapeutics market. It is expected to reach $21.79 billion by 2028, with a 3.6% compound annual growth rate (CAGR). The projected growth during the estimated period can be credited to ongoing research and development, worldwide health campaigns, change in patient treatment, government efforts, and heightened awareness of the disease. The major trends within this forecasted phase entail patient representation and support, continuous tracking and check-ups, health care equality, remote health services, and a concentrated effort towards eradicating hepatitis c.
Claim Your Free Sample of the Global Hepatitis Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9956&type=smp
What Are the Major Factors Contributing to the hepatitis therapeutics Market Expansion?
The global escalation of hepatitis infection is believed to drive the expansion of the hepatitis therapeutic market in the future. This increase in hepatitis infection stems from inadequate healthcare access and vaccination coverage, a surge in intravenous drug use, non-secure practices of blood transfusion, and less than adequate sanitation and hygiene situations in some regions globally. For instance, in April 2022, as stated by the World Health Organization (WHO), a public health agency of the United Nations based in the US, a minimum of 169 cases of acute hepatitis of unidentified origin were recorded from 11 countries, and 350 million people globally were reported to have viral hepatitis B or C. Yet for the majority of these people, access to testing and treatment remains unattainable. Consequently, the hepatitis therapeutics market continues to expand due to the surge in hepatitis infection.
Which Key Segments Shape the Hepatitis Therapeutics Market?
1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Drug Class: Oral Antivirals, Immune Modulators
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
What Are the Transformative Trends Influencing the Hepatitis Therapeutics Market?
The rise of product innovations is a critical trend noted in the hepatitis therapeutics market, with leading companies establishing new products to maintain their market standing. For example, US-based biotech company Gilead Sciences, Inc. was granted FDA approval in November 2022 for Vemlidy (tenofovir alafenamide), a new medication for treating paediatric patients suffering from chronic hepatitis B virus infection. Vemlidy is a specific prodrug of tenofovir that was first given FDA approval back in 2016 as a daily treatment for persons with chronic hepatitis B virus (HBV) infection and controlled liver disease. As per the American Liver Foundation’s guidelines, it is recommended as the preferred or initial treatment for individuals with chronic HBV and compensated liver disease.
Order Now for Fast Delivery of Your Hepatitis Therapeutics Market Report!
https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report
What Regions Are Leading the Growth Trajectory of the Hepatitis Therapeutics Market?
North America was the largest region in the hepatitis therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the hepatitis therapeutics market report during the forecast period. The regions covered in the hepatitis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Hepatitis Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the hepatitis therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Hepatitis Therapeutics Market Include
1. Hepatitis Therapeutics Market Executive Summary
2. Hepatitis Therapeutics Market Segments
3. Hepatitis Therapeutics Market Size And Template Market Growth Rate
4. Key Hepatitis Therapeutics Market Trends
5. Major Hepatitis Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Hepatitis Therapeutics Market
26. Top Hepatitis Therapeutics Companies
27. Hepatitis Therapeutics Market Opportunities And Strategies
28. Hepatitis Therapeutics Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
